Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Directory
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Catalent
Sort By
Newest First
1 / 2
Changing Roles
How are Advancements in Technology Reshaping the Roles and Capabilities of CDMOs and CROs in the Drug Development Life Cycle?
Pharma's Almanac
PAO-08-24-RT-01
Aug 07, 2024
Investment
What are the Current Investment Trends in the Pharmaceutical Industry, and How are They Influencing the Sector’s Direction?
Pharma's Almanac
PAO-06-24-RT-01
Jun 24, 2024
Real-World Data
How Is Your Organization Currently Leveraging Real-World Data/Evidence and What Uses Do You Anticipate in the Future?
Pharma's Almanac
PAO-09-23-RT-01
Sep 15, 2023
Industry Wisdom
What Piece of Conventional Industry Wisdom Do You Think is Misguided, Outdated, or Just Plain Wrong?
Pharma's Almanac
PAO-09-23-RT-02
Sep 15, 2023
Roundtable: Artificial Intelligence
In what areas of pharma/biopharma are you most excited to see increased adoption of artificial intelligence (AI) and machine learning?
Pharma's Almanac
PAO-07-23-RT-01
Jul 21, 2023
Roundtable: Patient Centricity
How is an increased focus on patient-centric concerns influencing the way that you work?
Pharma's Almanac
PAO-07-23-RT-02
Jul 21, 2023
Future of the Industry
What key indicators do you look at to predict the future of this industry?
Pharma's Almanac
PAO-10-022--RT-02
Oct 11, 2022
Sustainability
What is your plan to build a more sustainable business practice in the coming years?
Pharma's Almanac
PAO-10-022--RT-01
Oct 11, 2022
2021 Roundup: The Year of Cell and Gene Therapy
David Alvaro, Ph.D.
Pharma's Almanac
PA734
Dec 20, 2021
Catalent
Catalent to Acquire RheinCell Therapeutics, Strengthening a Path Towards Industrialization of Induced Pluripotent Stem Cell-based Therapies
Catalent
PA909
Jun 25, 2021
Gene Therapy
Planning for Success, Addressing Quality Early for Gene Therapies
Maribeth Donovan Janke, Ph.D.
Catalent
PAO-05-21-CL-02
May 21, 2021
Clinical Trial Logistics
Innovative Strategies to Maintain Product Integrity in Biologic and Biosimilar Clinical Studies
Mark Woolf
Catalent
PAO-03-21-CL-06
Mar 22, 2021
Chemistry, Manufacturing, and Controls
Phase-Appropriate CMC Activities Facilitate the Transition from Early Development through Commercialization
Matthew Rota; Lisa Caralli; Jim Spavins
Catalent
PAO-01-21-CL-05
Feb 05, 2021
Cell Therapy
Allogeneic T Cell Therapies: Efficient Commercial Manufacturing Readiness using “Manufacturing by Design” Methodology
Catalent
PAO-12-20-CL-01
Dec 16, 2020
COVID-19 vaccine
How COVID-19 Is Reshaping Vaccine Development: Innovations in Vaccine Technology and Partnerships
Graham Brearley, Ph.D.; Jared Davis, Ph.D.
Catalent
PAP-Q4-20-CL-007
Dec 09, 2020
Clinical Supply
Getting Your Biologic to Clinic Faster and More Efficiently
Ann McMahon; Pamela Barton
Catalent
PAP-Q3-20-CL-011
Sep 29, 2020
Catalent
COVID-19 Vaccine
Catalent Signs Agreement with AstraZeneca to Expand Manufacturing Support for COVID-19 Vaccine AZD1222
Catalent
PR-M08-20-NI-41
Aug 26, 2020
Catalent
Expansion
Catalent Adds Potent Manufacturing Capabilities at its Buenos Aires, Argentina Site
Catalent
PR-M08-20-NI-13
Aug 07, 2020
Catalent
COVID-19 Vaccine
Catalent Signs Agreement with Johnson & Johnson to be U.S. Manufacturing Partner for Lead COVID-19 Vaccine Candidate
Catalent
PR-M04-20-NI-044-1583
Apr 30, 2020
Perrigo
FDA Approval
Perrigo and Catalent Announce FDA Approval of Perrigo's AB-Rated Generic Version of ProAir® HFA
Perrigo
PR-M02-20-NI-041
Feb 27, 2020
1 / 2
